Annual D&A
$2.31 M
-$444.00 K-16.09%
December 31, 2023
Summary
- As of February 26, 2025, TCRT annual depreciation & amortization is $2.31 million, with the most recent change of -$444.00 thousand (-16.09%) on December 31, 2023.
- During the last 3 years, TCRT annual D&A has risen by +$1.19 million (+105.23%).
- TCRT annual D&A is now -16.09% below its all-time high of $2.76 million, reached on December 31, 2022.
Performance
TCRT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$0.00
-$1000.00-100.00%
September 30, 2024
Summary
- As of February 26, 2025, TCRT quarterly depreciation & amortization is $0.00, with the most recent change of -$1000.00 (-100.00%) on September 30, 2024.
- Over the past year, TCRT quarterly D&A has dropped by -$1000.00 (-100.00%).
- TCRT quarterly D&A is now -100.00% below its all-time high of $705.00 thousand, reached on December 31, 2021.
Performance
TCRT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$244.00 K
-$679.00 K-73.56%
September 30, 2024
Summary
- As of February 26, 2025, TCRT TTM depreciation & amortization is $244.00 thousand, with the most recent change of -$679.00 thousand (-73.56%) on September 30, 2024.
- Over the past year, TCRT TTM D&A has dropped by -$679.00 thousand (-73.56%).
- TCRT TTM D&A is now -91.22% below its all-time high of $2.78 million, reached on June 30, 2023.
Performance
TCRT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TCRT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.1% | -100.0% | -73.6% |
| 3 y3 years | +105.2% | -100.0% | -89.5% |
| 5 y5 years | +302.6% | -100.0% | -72.4% |
TCRT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | at low | -100.0% | at low | -91.2% | at low |
| 5 y | 5-year | -16.1% | +268.0% | -100.0% | at low | -91.2% | at low |
| alltime | all time | -16.1% | >+9999.0% | -100.0% | at low | -91.2% | +868.3% |
Alaunos Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $244.00 K(-73.6%) |
| Jun 2024 | - | $1000.00(-50.0%) | $923.00 K(-43.1%) |
| Mar 2024 | - | $2000.00(-99.2%) | $1.62 M(-30.0%) |
| Dec 2023 | $2.31 M(-16.1%) | $241.00 K(-64.5%) | $2.31 M(-16.4%) |
| Sep 2023 | - | $679.00 K(-2.9%) | $2.77 M(-0.4%) |
| Jun 2023 | - | $699.00 K(+0.4%) | $2.78 M(+0.5%) |
| Mar 2023 | - | $696.00 K(+0.3%) | $2.77 M(+0.3%) |
| Dec 2022 | $2.76 M(+6.2%) | $694.00 K(+0.4%) | $2.76 M(-0.4%) |
| Sep 2022 | - | $691.00 K(+0.9%) | $2.77 M(+0.7%) |
| Jun 2022 | - | $685.00 K(-0.6%) | $2.75 M(+0.2%) |
| Mar 2022 | - | $689.00 K(-2.3%) | $2.75 M(+5.7%) |
| Dec 2021 | $2.60 M(+130.2%) | $705.00 K(+4.8%) | $2.60 M(+12.3%) |
| Sep 2021 | - | $673.00 K(-0.9%) | $2.31 M(+18.1%) |
| Jun 2021 | - | $679.00 K(+25.7%) | $1.96 M(+28.2%) |
| Mar 2021 | - | $540.00 K(+28.6%) | $1.53 M(+35.3%) |
| Dec 2020 | $1.13 M(+79.3%) | $420.00 K(+32.1%) | $1.13 M(+27.6%) |
| Sep 2020 | - | $318.00 K(+28.2%) | $884.00 K(+22.3%) |
| Jun 2020 | - | $248.00 K(+74.6%) | $723.00 K(+14.6%) |
| Mar 2020 | - | $142.00 K(-19.3%) | $631.00 K(+0.3%) |
| Dec 2019 | $629.00 K(+9.4%) | $176.00 K(+12.1%) | $629.00 K(+2.1%) |
| Sep 2019 | - | $157.00 K(+0.6%) | $616.00 K(0.0%) |
| Jun 2019 | - | $156.00 K(+11.4%) | $616.00 K(+3.0%) |
| Mar 2019 | - | $140.00 K(-14.1%) | $598.00 K(+4.0%) |
| Dec 2018 | $575.00 K(+55.8%) | $163.00 K(+3.8%) | $575.00 K(+10.2%) |
| Sep 2018 | - | $157.00 K(+13.8%) | $522.00 K(+14.2%) |
| Jun 2018 | - | $138.00 K(+17.9%) | $457.00 K(+12.3%) |
| Mar 2018 | - | $117.00 K(+6.4%) | $407.00 K(+10.3%) |
| Dec 2017 | $369.00 K(+27.2%) | $110.00 K(+19.6%) | $369.00 K(+14.6%) |
| Sep 2017 | - | $92.00 K(+4.5%) | $322.00 K(+6.6%) |
| Jun 2017 | - | $88.00 K(+11.4%) | $302.00 K(+1.7%) |
| Mar 2017 | - | $79.00 K(+25.4%) | $297.00 K(+2.4%) |
| Dec 2016 | $290.00 K(-18.8%) | $63.00 K(-12.5%) | $290.00 K(+0.3%) |
| Sep 2016 | - | $72.00 K(-13.3%) | $289.00 K(+4.7%) |
| Jun 2016 | - | $83.00 K(+15.3%) | $276.00 K(-10.1%) |
| Mar 2016 | - | $72.00 K(+16.1%) | $307.00 K(-14.0%) |
| Dec 2015 | $357.00 K(-22.7%) | $62.00 K(+5.1%) | $357.00 K(-14.6%) |
| Sep 2015 | - | $59.00 K(-48.2%) | $418.00 K(-13.1%) |
| Jun 2015 | - | $114.00 K(-6.6%) | $481.00 K(+4.6%) |
| Mar 2015 | - | $122.00 K(-0.8%) | $460.00 K(-0.4%) |
| Dec 2014 | $462.00 K | $123.00 K(+0.8%) | $462.00 K(-6.7%) |
| Sep 2014 | - | $122.00 K(+31.2%) | $495.00 K(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $93.00 K(-25.0%) | $559.00 K(-15.7%) |
| Mar 2014 | - | $124.00 K(-20.5%) | $663.00 K(-10.2%) |
| Dec 2013 | $738.00 K(+12.2%) | $156.00 K(-16.1%) | $738.00 K(-4.7%) |
| Sep 2013 | - | $186.00 K(-5.6%) | $774.00 K(-1.9%) |
| Jun 2013 | - | $197.00 K(-1.0%) | $789.00 K(+6.8%) |
| Mar 2013 | - | $199.00 K(+3.6%) | $739.00 K(+12.3%) |
| Dec 2012 | $658.00 K(+145.5%) | $192.00 K(-4.5%) | $658.00 K(+17.1%) |
| Sep 2012 | - | $201.00 K(+36.7%) | $562.00 K(+28.3%) |
| Jun 2012 | - | $147.00 K(+24.6%) | $438.00 K(+25.5%) |
| Mar 2012 | - | $118.00 K(+22.9%) | $349.00 K(+30.2%) |
| Dec 2011 | $268.00 K(+42.6%) | $96.00 K(+24.7%) | $268.00 K(+29.5%) |
| Sep 2011 | - | $77.00 K(+32.8%) | $207.00 K(+24.0%) |
| Jun 2011 | - | $58.00 K(+56.8%) | $167.00 K(+5.7%) |
| Mar 2011 | - | $37.00 K(+5.7%) | $158.00 K(-16.0%) |
| Dec 2010 | $188.00 K(-43.0%) | $35.00 K(-5.4%) | $188.00 K(-18.6%) |
| Sep 2010 | - | $37.00 K(-24.5%) | $231.00 K(-16.6%) |
| Jun 2010 | - | $49.00 K(-26.9%) | $277.00 K(-11.8%) |
| Mar 2010 | - | $67.00 K(-14.1%) | $314.00 K(-4.8%) |
| Dec 2009 | $330.00 K(-14.9%) | $78.00 K(-6.0%) | $330.00 K(-8.5%) |
| Sep 2009 | - | $83.00 K(-3.5%) | $360.60 K(-1.9%) |
| Jun 2009 | - | $86.00 K(+3.6%) | $367.50 K(-3.8%) |
| Mar 2009 | - | $83.00 K(-23.6%) | $382.20 K(-1.5%) |
| Dec 2008 | $388.00 K(-10.5%) | $108.60 K(+20.8%) | $387.90 K(+5.8%) |
| Sep 2008 | - | $89.90 K(-10.7%) | $366.80 K(-16.7%) |
| Jun 2008 | - | $100.70 K(+13.5%) | $440.50 K(-2.8%) |
| Mar 2008 | - | $88.70 K(+1.4%) | $453.00 K(+4.5%) |
| Dec 2007 | $433.40 K(+149.2%) | $87.50 K(-46.5%) | $433.40 K(+7.6%) |
| Sep 2007 | - | $163.60 K(+44.5%) | $402.70 K(+43.6%) |
| Jun 2007 | - | $113.20 K(+63.8%) | $280.40 K(+35.9%) |
| Mar 2007 | - | $69.10 K(+21.7%) | $206.40 K(+18.7%) |
| Dec 2006 | $173.90 K(+71.8%) | $56.80 K(+37.5%) | $173.90 K(+19.3%) |
| Sep 2006 | - | $41.30 K(+5.4%) | $145.80 K(+11.1%) |
| Jun 2006 | - | $39.20 K(+7.1%) | $131.20 K(+14.3%) |
| Mar 2006 | - | $36.60 K(+27.5%) | $114.80 K(+13.4%) |
| Dec 2005 | $101.20 K(+197.6%) | $28.70 K(+7.5%) | $101.20 K(+24.5%) |
| Sep 2005 | - | $26.70 K(+17.1%) | $81.30 K(+1.9%) |
| Jun 2005 | - | $22.80 K(-0.9%) | $79.80 K(+40.0%) |
| Mar 2005 | - | $23.00 K(+161.4%) | $57.00 K(+67.6%) |
| Dec 2004 | $34.00 K(+4150.0%) | $8800.00(-65.1%) | $34.00 K(+34.9%) |
| Sep 2004 | - | $25.20 K | $25.20 K |
| Dec 2002 | $800.00(0.0%) | - | - |
| Dec 2001 | $800.00 | - | - |
FAQ
- What is Alaunos Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual D&A year-on-year change?
- What is Alaunos Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly D&A year-on-year change?
- What is Alaunos Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM D&A year-on-year change?
What is Alaunos Therapeutics annual depreciation & amortization?
The current annual D&A of TCRT is $2.31 M
What is the all time high annual D&A for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual depreciation & amortization is $2.76 M
What is Alaunos Therapeutics annual D&A year-on-year change?
Over the past year, TCRT annual depreciation & amortization has changed by -$444.00 K (-16.09%)
What is Alaunos Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of TCRT is $0.00
What is the all time high quarterly D&A for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly depreciation & amortization is $705.00 K
What is Alaunos Therapeutics quarterly D&A year-on-year change?
Over the past year, TCRT quarterly depreciation & amortization has changed by -$1000.00 (-100.00%)
What is Alaunos Therapeutics TTM depreciation & amortization?
The current TTM D&A of TCRT is $244.00 K
What is the all time high TTM D&A for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM depreciation & amortization is $2.78 M
What is Alaunos Therapeutics TTM D&A year-on-year change?
Over the past year, TCRT TTM depreciation & amortization has changed by -$679.00 K (-73.56%)